This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD (Ersa)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT05454956
Recruitment Status : Completed
First Posted : July 12, 2022
Last Update Posted : November 13, 2023
Information provided by (Responsible Party):
Tarsus Pharmaceuticals, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 18, 2023
Actual Study Completion Date : May 18, 2023